European Lead Factory releases high quality screening results

European Lead Factory successfully screening growing number of innovative biological targets.
Recent screening campaigns led to very promising results. Read more
Benefit from shared innovation in drug discovery. Meet us at the free seminar ‘Shared Innovation in Drug Discovery’ in London, Dec10th. Read more
Promising new leads found in fight against malaria

Malaria kills around 600,000 - 700,000 people annually, primarily in sub-Saharan Africa. New therapeutics are imperative to control this infectious disease.
Consortium partners
achieved promising new results in TI Pharma project aimed at generating antimalarial compounds with novel action mechanisms. Read more
Pediatric Praziquantel Consortium rapidly moving ahead

TI Pharma coordinates efforts in a consortium developing a pediatric version of praziquantel, a drug to treat schistosomiasis.
Pediatric Praziquantel Consortium sees rapid and steady progress. Read more
Pediatric Praziquantel Consortium recognized at 2014 Corporate Engagement Awards with ‘silver’ medal. Read more
CTMM presents innovative research results

The Center for Translational Molecular Medicine (CTMM) Annual Meeting was held in Utrecht on November 4th and showcased a wide range of scientific, clinical and economic results from the Dutch government co-funded CTMM portfolio which is concluding in 2015. Many successes achieved over the past seven years were displayed. Read more
Escher helps optimization across EU regulatory system

Escher, the TI Pharma platform for regulatory innovation, analyzes scientific evidence to improve EU system for marketing authorization.
View report: ‘Improving the EU system for the marketing authorization of medicines’. Read more
New Escher project ‘Pharmacovigilance of biologics’ launched. 
Read more
Have a happy festive break & a prosperous 2015!

We hope that 2014 has been a successful year for you. It has been a very productive year for TI Pharma. Projects generated great results. New projects continue to be launched. Our merger with CTMM, enables us to better address the growing interdependence of medicines & medical technology.
We look forward to continue collaborating with you in 2015!
Our mailing address is:

TI Pharma
Galileiweg 8
Leiden, 2333 BD

Add us to your address book

Copyright © 2014 TI Pharma. All rights reserved.

change your subscription
delete your subscription

If you need assistance, please contact us at